Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Fisher Scientific has entered a definitive agreement to acquire privately held Athena Diagnostics, a developer of neurologic, nephrologic, and endocrine diagnostic tests, from Behrman Capital for $283 million. Fisher also agreed to buy a 9% stake in Nanogen, a manufacturer of diagnostic equipment, microarrays, and reagents, for $15 million. Fisher says it will collaborate with Nanogen to develop Athena's proprietary markers and diagnostic assays.
This article has been sent to the following recipient: